Clearside Biomedical holds KOL webinar on suprachoroidal delivery; no new financial data

Clearside Biomedical, Inc.

Company hosted virtual Suprachoroidal Delivery KOL Webinar on July 24, 2024.
Attached slide presentation (Exhibit 99.1) contains only a title slide with no substantive data.
No material financial or business updates were disclosed in the filing.

item 7.01 item 9.01

Clearside Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-085864

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.